The changes and the prognostic impacts of the levels of secretory type II phospholipase A2 and C-reactive protein in patients with CAD undergoing percutaneous coronary intervention after 2-year follow up.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalProceedings of the 32nd Annual Scientific Session of the Taiwan Society of Cardiology.
Publication statusPublished - 2002 May

Cite this